Physician profile
Paula Bennett
NPI 1245292556
$6,136.50
in general payments reported to CMS, 2019-2025
49 companies · $1,050 in 2025
The $1,050 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $458 · 2021: $841 · 2022: $1,156 · 2023: $1,403 · 2024: $944 · 2025: $1,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,397.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $946.70 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $837.05 | 2019-2025 | Trelegy Ellipta, Arexvy, Bexsero |
| Novo Nordisk INC | $741.35 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $527.91 | 2019-2025 | Evenity, Prolia, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $453.92 | 2021-2025 | |
| Pfizer INC. | $323.16 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $248.41 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Otsuka America Pharmaceutical, INC. | $220.74 | 2022-2024 | Rexulti |
| Lilly USA, LLC | $213.66 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $195.07 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Nestle Healthcare Nutrition INC. | $143.90 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $103.62 | 2019-2022 | |
| Eisai INC. | $101.65 | 2021-2024 | |
| Astellas Pharma US INC | $93.92 | 2020-2023 | Veozah, Myrbetriq |
| Dexcom, INC. | $84.13 | 2022-2025 | Dexcom G6 Transmitter |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.